Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 0.360.360.340.340.70

What is the latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 0.36 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20240.36
Mar20230.36
Mar20220.34
Mar20210.34
Mar20200.70

How is Fixed Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2024 0.36
0.00
Mar2023 0.36
5.88
Mar2022 0.34
0.00
Mar2021 0.34
-51.43
Mar2020 0.7 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹41,680.9 Cr -7.3% -4.8% 72.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,527.0 Cr -3.8% -3% 34.3% Stock Analytics
DIVIS LABORATORIES ₹156,037.0 Cr 0.9% 0.4% 53.5% Stock Analytics
CIPLA ₹116,854.0 Cr -2.8% -0.1% 9.3% Stock Analytics
DR REDDYS LABORATORIES ₹111,746.0 Cr -2.4% 5.5% 17.5% Stock Analytics
ZYDUS LIFESCIENCES ₹99,093.9 Cr -2.4% -0.3% 42.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-7.3%

-4.8%

72.3%

SENSEX

-1.8%

-6.6%

7.1%


You may also like the below Video Courses